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Abstract
Background: Transcriptome profiling of patterns of RNA expression is a powerful approach to identify networks of genes
that play a role in disease. To date, most mRNA profiling of tissues has been accomplished using microarrays, but next-
generation sequencing can offer a richer and more comprehensive picture.
Methodology/Principal Findings: ECO is a rare multi-system developmental disorder caused by a homozygous mutation in
ICK encoding intestinal cell kinase. We performed gene expression profiling using both cDNA microarrays and next-
generation mRNA sequencing (mRNA-seq) of skin fibroblasts from ECO-affected subjects. We then validated a subset of
differentially expressed transcripts identified by each method using quantitative reverse transcription-polymerase chain
reaction (qRT-PCR). Finally, we used gene ontology (GO) to identify critical pathways and processes that were abnormal
according to each technical platform. Methodologically, mRNA-seq identifies a much larger number of differentially
expressed genes with much better correlation to qRT-PCR results than the microarray (r
2=0.794 and 0.137, respectively).
Biologically, cDNA microarray identified functional pathways focused on anatomical structure and development, while the
mRNA-seq platform identified a higher proportion of genes involved in cell division and DNA replication pathways.
Conclusions/Significance: Transcriptome profiling with mRNA-seq had greater sensitivity, range and accuracy than the
microarray. The two platforms generated different but complementary hypotheses for further evaluation.
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Introduction
New technologies permit the evaluation of global patterns of
gene expression – mRNA levels – from healthy and diseased
tissues. The simultaneous assessment of changes in expression of
many genes – up to the whole genome level – can then be analysed
simultaneously using bioinformatic tools that can reveal new
patterns or networks of differentially regulated genes [1]. These
technologies have transformed our conception of the molecular
mechanisms underlying complex diseases such as cancer and
degenerative illnesses [2,3]. Over the past five years, microarrays –
which are a hybridization-based technology – have been the main
platform used for transcription profiling. However, within the last
two years, high throughput next-generation mRNA sequencing
methods now allow for quantitative measurement of expression
levels on a genome-wide basis at the level of a single nucleotide.
We had the opportunity to compare technologies used to
generate expression profiles of cultured fibroblasts from Amish
children with a rare autosomal recessive condition called
endocrine-cerebro-osteodysplasia (ECO; MIM 612651). ECO is
a multi-system neonatal lethal disorder – a kinasopathy [4] –
affecting mainly the skeletal, cerebral and endocrine systems that
results from a homozygous nonsynonymous mutation (R272Q) in
the ICK gene encoding intestinal cell kinase [5]. ICK, also known
as MAK-related kinase (MRK), is ubiquitously expressed,
particularly in brain, spinal cord, testis, and ovary [6,7,8].
Catalytic domains of ICK share ,40% identity with those of
consensus MAPKs, which are regulators of cell-cycle entry and
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Residue 272 lies within the nuclear localization signal sequence
[5,9] and the R272Q mutation both impairs nuclear localization
and reduces catalytic activity [5].
Since very little was known about the downstream biological
pathways and gene networks that were affected in ECO patients,
we profiled the transcriptomes of cultured skin fibroblasts from
ECO patients. We used 2 independent technological platforms to
accomplish this, namely cDNA microarrays and next-generation
mRNA sequencing (mRNA-seq). This provided a unique
opportunity to validate the findings of each platform using
quantitative RT-PCR (qRT-PCR) and to compare the networks
of genes that were identified by GOStat, a database that lists all
the overrepresented GO terms according to statistical significance
[10], and KEGG pathway, a collection of manually curated
pathway maps [11].
Materials and Methods
Participants and Ethics Statement
Primary skin fibroblasts from two subjects affected with ECO
(designated 030950 and 040786) and one unrelated unaffected
from the community (070280) were obtained from forearm
puncture biopsies from affected individuals. The skin fibroblast
line AG03348 (or 3348) was obtained from the Coriell Cell
Repository (Coriell Institute for Medical Research, Camden NJ),
and served as another unaffected non-Amish control cell line.
Cultured primary skin fibroblasts were maintained at 37uC and
5% CO2 in Ham’s F-10 medium (Gibco, Carlsbad CA) with L-
glutamine supplemented with 10% fetal bovine serum and 16
antibiotic/antimycotic mixture (Gibco). For passaging, cells were
released from the dish using 0.1% (w/v) trypsin and 0.02% (w/v)
EDTA washes and re-distributed onto another dish. Samples from
all passages were stored in 280uC.
Tissue samples were provided for research purposes, with
approval by the Office of Research Ethics (University of Western
Ontario). Participating parents provided informed consents and
did not receive any financial compensation.
Skin Fibroblast Cell Line Doubling Measurements
Each cell line was passaged and maintained in 90 mm diameter
dishes (Gibco) two to three times weekly. After release using
trypsin and EDTA, washed cells were diluted in enriched Ham’s
F-10 medium. Ten microlitres of re-diluted cells were counted
using a haemocytometer and seeded on fresh culture dishes. Cell
number counted (n) was used to calculate the number of cells per
mL (N), with the formula N=n610
4. This procedure was carried
out until the same number of cells or fewer was obtained from sub-
culturing over three consecutive passages. Cell growth was
measured by calculation of population doubling (PD) using the
formula:
PD~ logH{logS ðÞ =log 2:0,
where log H is the logarithm of the number of cells harvested after
3 or 4 days of growth and log S is the logarithm of the number of
cells on the first day of each passage. Accumulated population
doublings (APD) were calculated by the summation of PDs.
RNA Isolation
For each cell line, RNA from a ‘‘young’’ cultured age passage
was extracted at an APD of 3–5 whereas RNA from an ‘‘old’’
cultured age passage was extracted at an APD of ,20–22. In total
8 samples were extracted, with young and old passages for affected
cell lines 030950 and 040786 and for unaffected cell lines 070280
and 3348. RNA was extracted from cultured skin fibroblasts using
the RNEasy kit (Qiagen, Mississauga, ON). Briefly, cells were lysed
with a buffer containing guanidine-isothiocyanate and b-mercap-
toehtanol. Genomic DNA was sheared using a Shredder column
(Qiagen). Ethanol was added to the resulting solution allowing the
RNA to bind to the silicia-gel-membrane spin column. Bound
RNA was washed with ethanol and eluted with RNAse-free water.
Once RNA was extracted, its concentration and purity were
measured using the NanoDrop spectrophotometer (Thermo
Scientific; Ottawa, ON) and the Agilent 2100 Bioanalyzer (Agilent
Technologies; Palo Alto, CA). Samples were stored at 280uC.
cDNA Microarray Hybridization and Analysis
All microarrays were processed at the London Regional
Genomics Centre (http://www.lrgc.ca). Biotinylated RNA was
prepared from 2 mg of total RNA using the two–cycle amplifica-
tion protocol. Double-stranded cDNA was synthesized using
SuperScript II (Invitrogen, Carlsbad, CA) and oligonucleotide
primers. Biotin-labelled complementary RNA (cRNA) with
incorporated biotinylated UTP and CTP was prepared using in
vitro transcription of cDNA with the Bizarre High-Yield RNA
Transcript Labeling kit (Enzo Brioche, New York, NY). Fifteen
micrograms of labelled cRNA was hybridized to Human 1.0 ST
array GeneChips for 16 h at 45uC (Affymetrix, Santa Clara, CA).
The chips were stained with streptavidin-phycoerythrin solution.
Liquid handling was performed by the GeneChip Fluidics Station
450 (Affymetrix) and arrays were scanned using the GeneChip
Scanner 3000 (Affymetrix). Signal intensities for genes were
generated using GCOS1.4 (Affymetrix) using default values for the
Statistical Expression algorithm parameters. Probe level data was
imported into Genomics Suite software (Partek, St. Louis, MO);
the student’s paired t test was used to detect differences between
them.
mRNA Deep Sequencing Platform Hybridization and
Analysis
Five mg of total RNA was processed using proprietary kits from
Illumina (Hayward, CA). Briefly, PolyA
+ RNA was isolated from
total RNA fragmented using Ambion RNA fragmentation buffer.
cDNA synthesis was performed with Invitrogen random hexamer
primers and cDNA was purified using QIAquick PCR spin
column (Qiagen). Ends were blunted and 39-A overhangs
introduced using T4 DNA polymerase and E. coli DNA
polymerase I Klenow fragment. cDNAs were ligated to adapters
with a single ‘T’ base overhang. After selection of 150–200 bp
fragments from 2% low-range agarose gel, samples were amplified
by 18 PCR cycles to enrich cDNAs with correctly ligated adapters
and to amplify the amount of DNA in the library. Samples were
loaded on a Cluster Station to create flow cells of clonal single
molecular array (CSMA) and sequenced on the Illumina platform
[12]. The analysis pipeline encompassed primary data acquisition,
base calling, and calculating confidence scores from the fluores-
cence signals on the Genome Analyzer. Each transcriptome was
sequenced at a depth of 30–40 million single reads, with read
lengths up to 75 bp. Raw reads were converted to FASTQ data
format since this format compactly stores a quality score for each
base, which could be used to filter individual sequences. The
quality-filtered reads were then aligned by TopHat [13], which
map them to both the UCSC reference human genome and exon-
exon splice junctions as annotated by Ensembl. Cufflinks [14] then
provided the gene expression levels, based on the TopHat
alignments and Ensembl annotation. Gene expression was
quantified as ‘reads per kilobase of exon model per million
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RPKM — that is, the transcript of the gene was present if there
were $10 reads that mapped uniquely to a single genomic locus.
More than 18,815 Ensembl annotated protein-coding genes were
compared to create a gene list of differentially expressed genes
based on disease status of the cell lines. Transcript level data were
then imported into Genomics Suite (Partek, St. Louis, MO) for
additional analyses; comparisons were performed using student’s
paired t test.
Quantitative RT-PCR
For the mRNA-seq platform gene list, two probes per gene were
chosen for FBLN5, EMP1, CHPF, EXT1, CRIP1, MEST, STC2,
AFAP1, DKK2, LRRK2, LXN, FAM20A, DYNC1I1, KIF23, and
GPR160, while one probe was chosen for SOD3, RAP1B, CCRL1,
and HTR1B based on probe availability (Gene Expression Assay,
Applied Biosystems, Carlsbad, CA). qRT-PCR standard curves for
FBLN5, EMP1, SOD3, CHPF, CRIP1, DKK2, LRRK2, CCRL1,
FAM20A, and DYNC1I1 were acquired using cell line 070280,
while cell line 030950 was used to derive standard curves for
EXT1, MEST, STC2, RAP1B, AFAP1, LXN, KIF23, GPR160, and
HTR1B.
Total RNA (100 ng) was reverse transcribed using the High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems)
in a 20 mL reaction volume and amplified using TaqMan Assay
probes (Applied Biosystems) in a 7900 HT Real Time PCR
System (Applied Biosystems) with the 40 cycle amplification
protocol. Amplified sequences were detected using the Prism
sequence detector (Applied Biosystems) according to manufactur-
er’s instructions. Experiments were done in triplicate, using
GAPDH as an internal reference, on the young and old age
passages from affected cell lines 030950 and 040786 and from
unaffected cell lines 070280 and 3348. Expression values were
standardized to values obtained with the standard RNA using the
delta Ct method. Standard curves had r
2 values.0.98.
Biological Interpretations
The cDNA microarray data set was first run on the gene
ontology (GO)-ANOVA analysis tool (Partek). The mRNA-seq
data set was also biologically interpreted using GO through a web-
Figure 1. Growth characteristics of skin fibroblasts from ECO-affected and unaffected individuals. The accumulated population
doublings (y-axis) achieved at indicated time in culture (x-axis) for four fibroblast cell lines. The fibroblast cell lines include: two homozygous normal
subjects (070280 and 3348) and the two homozygous affected subjects (030950 and 040786).
doi:10.1371/journal.pone.0025400.g001
Table 1. Fold change distribution of differentially expressed genes based on disease status using both platforms (P#0.05).
Platform Fold change
$30 $20 $10 $5 $2 $1
Upregulated genes in ECO-Affected cDNA microarray 0 0 2 6 62 618
mRNA-seq 11 16 42 99 453 1179
Downregulated genes in ECO-Affected cDNA microarray 0 1 3 11 144 974
mRNA-seq 5 7 29 74 255 457
Total differentially expressed genes cDNA microarray 0 1 5 17 206 1592
mRNA-seq 16 23 71 173 708 1636
doi:10.1371/journal.pone.0025400.t001
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statistically overrepresented GO terms within the provided data
set. In addition, gene lists based on disease status from the
microarray and the RNA-seq platforms were analyzed by Pathway
Express (http://vortex.cs.wayne.edu/projects.htm), which uses the
KEGG pathway database to define biological and cellular
functions.
Results
Hyperproliferation of Cultured Skin Fibroblasts from
ECO-Affected Individuals
The complete lifespan growth curves of the cell lines are shown
(Figure 1). To reach senescence, the 030950 cell line was passaged
27 times for 96 days, 040786 was passaged 25 times for 88 days,
070280 was passaged 25 times for 88 days, and 3348 was passaged
19 times for 66 days. The mean PD from the 2 normal fibroblast
lines was 0.5960.03, while the mean PD for the 2 ECO-affected
fibroblast cell lines was 1.0760.05 (P,0.05). These findings,
obtained from experiments performed in duplicate, indicated an
approximate doubling of the proliferation rate in affected skin
fibroblasts compared to unaffected skin fibroblasts.
Transcriptome Profiling
Both microarray and mRNA-seq platforms showed consistently
high numbers of genes that were differentially expressed in ECO-
affected versus unaffected fibroblasts. Table 1 shows a comparison
of the number of significantly differentially expressed genes based
on fold change determined by each platform. Overall, mRNA-seq
identified a greater number of differentially expressed genes with
fold changes $2.0 than microarrays (708 versus 206, respectively),
with virtually identical numbers of genes with fold changes
between 1.0 and 2.0 (1636 versus 1592, respectively) indicating
that mRNA-seq was more sensitive in identifying significantly
differentially expressed genes than the cDNA microarray.
The cDNA microarray identified more downregulated genes,
while the mRNA-seq platform identified more upregulated genes.
Most differentially expressed genes from the cDNA microarray had
a fold-change range from 2 to 10, while the differentially expressed
genes from the mRNA-seq platform had a greater range in fold-
change values, and many more genes with fold changes $20.0.
We next validated 20 significant differentially expressed genes
from the mRNA-seq platform using qRT-PCR. Candidate genes
were chosen based on conventional criteria [16] such as .2-fold
change between conditions, with P#0.05, regardless of the ‘age’ or
passage number (see Table 2). By inspection, the direction and
degree of fold- changes were more similar to the qRT-PCR
findings for mRNA-seq identified genes than for microarray
identified genes. Also, by inspection, there appeared to be
systematic underestimation in fold-change values from the cDNA
microarray data set, for about half of the validation gene set,
namely SOD3, CRIP1, MEST, DKK2, LXN, CCRL1, FAM20A,
DYNC1I1, HTR1B, and RASGRP1. Also, 5 genes, namely STC2,
Table 2. Comparison of fold change values of 20 genes (with P#0.05) selected from the mRNA-seq platform to qRT-PCR and cDNA
microarray.
Gene symbol Gene Name mRNA-seq data (P#0.05)
qRT-PCR
(Fold change)
cDNA microarray
(Fold change)
Affected
a Unaffected
a Fold change
AFAP1 Actin filament associated protein 1 75.1 37.5 2.00 1.97 1.94
CCRL1
b Chemokine (C-C motif) receptor-like 1 0.19 22.8 2119.3 298.3 21.87
CHPF Chondroitin polymerizing factor 142.3 231.9 21.63 21.80 21.59
CRIP1 Cysteine-rich intestinal protein 1 39.0 95.0 22.44 26.32 21.81
DKK2 Dickkopf homolog 2 0.16 2.81 218.1 217.3 22.30
DYNC1I1 Dynein, cytoplasmic 1, intermediate chain 1 0.02 0.56 230.8 235.9 21.08
c
EMP1 Epithelial membrane protein 1 99.4 217.2 22.18 22.06 22.72
EXT1 Exostosin 1 184.3 104.3 1.77 1.95 1.55
FAM20A Family with sequence similarity 20, member A 0.27 7.48 227.7 232.2 22.04
FBLN5 Fibulin-5 73.1 172.8 22.36 22.60 22.03
GPR160 G protein-coupled receptor 160 0.78 0.02 41.8 1.37 1.08
c
HTR1B
b 5-hydroxytryptamine (serotonin) receptor 1B 0.87 0.01 62.0 4.15 1.51
KIF23 Kinesin family member 23 601.9 2.03 295.9 1.17 1.30
c
LRRK2 Leucine-rich repeat kinase 2 0.05 1.30 227.1 229.8 n/a
LXN Latexin 10.7 0.10 111.4 166.3 2.22
MEST Mesoderm-specific transcript homolog 83.6 4.56 18.3 36.7 1.80
RAP1B
b Ras-related protein 1b 78.9 39.1 2.02 1.46 21.21
c
RASGRP1 RAS guanyl releasing protein 1 (calcium and
DAG-regulated)
19.1 0.47 40.3 35.7 17.3
SOD3
b Superoxide dismutase 3, extracellular 6.44 81.1 212.6 225.1 21.44
STC2 Stanniocalcin 2 149.3 85.9 1.74 1.90 1.52
c
avalues based on RPKM normalization;
bone qRT-PCR probe used;
cnot significant.
doi:10.1371/journal.pone.0025400.t002
Transcriptional Profiling of ECO Syndrome
PLoS ONE | www.plosone.org 4 September 2011 | Volume 6 | Issue 9 | e25400RAP1B, DYNC1I1, KIF23 and GPR160 were not statistically
different in terms of gene expression between the platforms. There
was much better correlation between the mRNA-seq platform and
qRT-PCR values (r
2=0.794, P=7.10610
27, Figure 2A) than
between the cDNA microarray and qRT-PCR (r
2=0.137,
P=0.12, Figure 2B).
Biological Interpretations of Differentially Expressed
Genes
Using GOStat [10] we determined the top 20 overrepresented
GO terms based on the total number of genes that were
significantly (P,0.05) differentially expressed from microarray
and mRNA-seq platforms (Tables 3 and 4, respectively). GO
categories identified as significant by microarray tended towards
anatomical and organ development and morphogenesis. In
contrast, GO categories identified as significant by mRNA-seq
data tended towards genes involved in cell cycling and cell
division. Together, the findings suggest that differentially
expressed genes in the ECO syndrome are found in pathways
involved in the proliferation and regulation of cell cycle.
We also evaluated the top GO categories in ECO-affected cells
versus unaffected cells using KEGG pathway analysis for the
microarray and mRNA-seq data sets (Tables 5 and 6, respectively).
Interestingly, although several overrepresented pathways were the
same using data from each platform, the most significant pathway
- found from the mRNA-seq data - was the cell cycle. Overall,
KEGG pathway analysis suggested downstream transcriptional
consequences of the germline ICK mutation affect JAK-STAT and
Wnt signalling pathways, cell adhesion and cytoskeletal structure,
consistent with a role in regulation of cell proliferation.
Figure 2. Correlation graphs of the fold change of the 18 genes selected from the mRNA-seq platform. (A) The fold-change values from
the mRNA-seq data (x-axis) are plotted against the fold change value from the qRT-PCR experiments (y-axis), giving good correlation (r
2=0.794,
P=7.10610
27). (B) The fold-change values from the cDNA microarray data (x-axis) are plotted against the fold change value from the qRT-PCR
experiments (y-axis), with non-significant correlation (r
2=0.137, NS).
doi:10.1371/journal.pone.0025400.g002
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We used two different methods, namely cDNA microarrays and
the mRNA deep sequencing platform, to profile transcriptomes of
fibroblasts from patients with ECO syndrome due to the
homozygous R272Q mutation in ICK. We identified a hyperpro-
liferative phenotype for cultured ECO cells and showed
differential expression of genes involved in cell growth and
proliferation. We also had a unique opportunity to compare the
findings of these two platforms. We found that the mRNA-seq
platform was more sensitive in identifying significantly differen-
tially expressed genes than the cDNA microarray platform. Also,
correlation with qRT-PCR validation experiments of fold-changes
with mRNA-seq was also superior compared to cDNA micro-
arrays. It is interesting to note that results from cDNA microarray
and qRT-PCR do not correlate well for the top 20 genes acquired
from the mRNA-seq platform data, indicating that although qRT-
PCR shows biological differences for these genes, their changes in
expression were not appreciated using the cDNA microarray. This
also implies that the cDNA microarray platform contains
numerous false-negatives, which may lead to inaccurate conclu-
sions about the transcripts expressed in cases versus controls.
Initially transcription profiling studies largely relied on hybrid-
ization-based technologies. However with the introduction of
mRNA-seq technology, RNA analysis through deep sequencing is
achievable on a massive scale. Although the discussion of the
advances and challenges of both platforms used here is beyond the
scope of this paper, we will briefly address them. The microarray-
based approach to study gene expression is high throughput and
relatively inexpensive; however it has a limited range of detection
due to both background and saturation of signals [17] and seems
largely limited in its ability to catalogue and quantify diverse RNA
molecules due to the reliance on probes for pre-specified targets
[18]. mRNA-seq technology, on the other hand, has highly
reproducible results with relatively little technical variation and
has the potential to detect and quantify RNAs with low and
moderate abundance since this approach digitally counts sequence
reads [19]. However, by using sequence reads for RNA
quantification, other issues arise; for instance, a small number of
very highly expressed genes (7%) accounts for most of the reads
(75%) [20]. More specifically in this study RPKM (Reads Per
Kilobase of exon model per Million mapped reads), was the unit of
measurement used to quantify transcript abundance. However,
this unit is biased towards larger genes and ignores the fact that
that different isoforms of a gene may be of different lengths [14].
Recently, others have compared the results of deep sequencing-
and microarray-based transcriptional profiling in a mouse model
of cardiomyopathy [21]. As we have now shown with our human
transcriptome findings, those authors similarly concluded that
mRNA-seq was sensitive and reliable in quantifying lower-
abundance genes, which represented the majority of the regulated
genes in their model.
We note that skin fibroblasts of the affected individuals were
hyperproliferative in culture compared to those from normal
individuals, which was consistent with the presumed role of ICK as
a human cyclin-dependent kinase 2 (CDK2) member of the
MAPK family. MAPKs are regulators of cell cycle and thus of
cellular proliferation and apoptosis [22]. The expression experi-
Table 3. Top 20 overrepresented Gene Ontology (GO) terms
using GOStat in the cDNA microarray data set (based on
disease status, P#0.05 and $62.0 fold change, 206 genes).
GO ID GO category P-value
# Genes/
GO ID
48856 anatomical structure development 5.84610
214 39
7275 multicellular organismal development 8.70610
214 42
32502 developmental process 6.80610
213 52
32501 multicellular organismal process 5.57610
211 54
48731 multicellular organismal system
development
5.18610
210 30
48513 organ development 2.00610
27 22
8283 cell proliferation 2.13610
27 21
7165 signal transduction 9.44610
27 58
7154 cell communication 1.04610
26 61
9653 anatomical structure morphogenesis 1.04610
26 20
65007 biological regulation 1.75610
25 67
65008 regulation of biological quality 7.38610
25 17
48523 negative regulation of cellular process 7.38610
25 19
48519 negative regulation of biological process 1.76610
24 19
48869 cellular developmental process 2.16610
24 25
30154 cell differentiation 2.16610
24 25
50789 regulation of biological process 3.63610
24 59
50794 regulation of cellular process 7.33610
24 55
7259 JAK-STAT cascade 2.73610
23 4
9605 response to external stimulus 2.73610
23 13
doi:10.1371/journal.pone.0025400.t003
Table 4. Top 20 overrepresented Gene Ontology (GO) terms
using GOStat in the mRNA-seq data set (based on disease
status, P#0.05 and $62.0 fold change, 708 genes).
GO ID GO category P-value
# Genes/
GO ID
278 mitotic cell cycle 3.98610
253 44
279 M phase 5.26610
252 42
22403 cell cycle phase 6.64610
248 45
22402 cell cycle process 1.37610
242 58
7049 cell cycle 4.51610
241 68
48856 anatomical structure development 2.50610
230 105
8283 cell proliferation 1.05610
229 56
7275 multicellular organismal development 5.74610
229 113
32502 developmental process 5.74610
229 145
32501 multicellular organismal process 5.72610
228 157
48731 multicellular systemic organismal
development
9.09610
226 86
48513 organ development 1.38610
224 68
87 M phase of mitotic cell cycle 2.21610
224 40
7067 mitosis 8.97610
224 39
51301 cell division 2.17610
223 39
65007 biological regulation 2.27610
218 211
50789 regulation of biological process 1.37610
214 188
74 regulation of progression through cell cycle 3.22610
214 27
48869 cellular developmental process 6.84610
214 77
30154 cell differentiation 6.84610
214 77
doi:10.1371/journal.pone.0025400.t004
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and palate, polydactyly, and dysplastic organs, support a role for
ICK as a regulator of cell growth. Functionally, GO analysis
showed some overlap between microarray and mRNA-seq data
with respect to overrepresented pathways in cells from ECO
patients. However, emphasis on biological pathway involvement is
based on platform selection, such that cDNA microarray
concentrates on pathways with phenotypic relevance to the
disorder, while the mRNA-seq platform identifies a higher
proportion of upstream genes involved in cell division and DNA
replication pathways. It would be of interest to examine
transcription profiles in cells of other types and from other tissues
in ECO patients. Thus, mRNA-seq discovered more differentially
expressed genes and showed better correlation with qRT-PCR
than did microarrays in cultured skin fibroblasts from ECO
patients. Because of the growing use and accessibility of new
genomic technologies for clinical applications, the findings show
that results should be carefully interpreted, since different methods
can generate very different hypotheses. Further, the findings
emphasize the importance of validation of high-throughput
genome-wide approaches using an independent method, such as
qRT-PCR.
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